Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. N. Rexer
Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
Cancer Research
Cancer Research
Oncology
Related publications
Her2 Cross Talk and Therapeutic Resistance in Breast Cancer
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis
Modern Pathology
Forensic Medicine
Pathology
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Clinical Medicine Insights: Oncology
Oncology
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
MYC Is Amplified in BRCA1-Associated Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Cancer Stem Cell Plasticity Drives Therapeutic Resistance
Cancers
Cancer Research
Oncology
A Phenotypic and Mechanistic Perspective on Heterogeneity of HER2-positive Breast Cancers
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Molecular Cancer Therapeutics
Cancer Research
Oncology
Identification of New miRNA Biomarkers Associated With HER2-positive Breast Cancers
Oncoscience
Cancer Research
Oncology